Brief: Purapharm Corp Says Guangxi Zhuang Autonomous Region FDA Approved Application For Unit To Manufacture Qing Fei Pai Du Tang Granule
24/02/2020 06:55
Feb 24 (Reuters) - PuraPharm Corp Ltd 1498.HK :
* GUANGXI ZHUANG AUTONOMOUS REGION FDA APPROVED APPLICATION
FOR
UNIT TO PREPARE & MANUFACTURE QING FEI PAI DU TANG GRANULE
Source text for Eikon: ID:nHKS3qNjJh
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln